Ernexa Therapeutics Inc. financial statements
Ernexa Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 14.08M | 10-K |
| Cash and equivalents | USD 1.88M | 10-Q |
| Total debt | USD 490K | EODHD |
Ernexa Therapeutics Inc. financials on 6ix · Ernexa Therapeutics Inc. on 6ix